Fatou Traoré

Emergence of Multiclass Drug–Resistance in HIV‐2 in Antiretroviral‐Treated Individuals in Senegal: Implications for HIV‐2 Treatment in Resouce‐Limited West Africa

Geoffrey S. Gottlieb, Ndèye Méry Dia Badiane, Stephen E. Hawes et al. · Clinical Infectious Diseases · 2009 · 83 citations

Life Sciences, Infectious Diseases, Pharmacology +17

Complex Patterns of Protease Inhibitor Resistance among Antiretroviral Treatment-Experienced HIV-2 Patients from Senegal: Implications for Second-Line Therapy

Dana N. Raugi, Robert A. Smith, Selly Ba et al. · Antimicrobial Agents and Chemotherapy · 2013 · 50 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

A Trial of a Single-tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate for the Initial Treatment of Human Immunodeficiency Virus Type 2 Infection in a Resource-limited Setting: 48-Week Results From Senegal, West Africa

Selly Ba, Dana N. Raugi, Robert A. Smith et al. · Clinical Infectious Diseases · 2018 · 35 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

HIV-2 Integrase Variation in Integrase Inhibitor-Naïve Adults in Senegal, West Africa

Geoffrey S. Gottlieb, Robert A. Smith, Ndèye Méry Dia Badiane et al. · PLoS ONE · 2011 · 29 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali

Fatou Traoré, Emmanuelle Gormally, Stéphanie Villar et al. · BMC Infectious Diseases · 2015 · 17 citations · Full text

Medicine, Infectious Diseases, Molecular Biology +17